These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1381 related items for PubMed ID: 27342558

  • 1. Phage Therapy Is Effective in a Mouse Model of Bacterial Equine Keratitis.
    Furusawa T, Iwano H, Hiyashimizu Y, Matsubara K, Higuchi H, Nagahata H, Niwa H, Katayama Y, Kinoshita Y, Hagiwara K, Iwasaki T, Tanji Y, Yokota H, Tamura Y.
    Appl Environ Microbiol; 2016 Sep 01; 82(17):5332-9. PubMed ID: 27342558
    [Abstract] [Full Text] [Related]

  • 2. Pseudomonas aeruginosa keratitis in mice: effects of topical bacteriophage KPP12 administration.
    Fukuda K, Ishida W, Uchiyama J, Rashel M, Kato S, Morita T, Muraoka A, Sumi T, Matsuzaki S, Daibata M, Fukushima A.
    PLoS One; 2012 Sep 01; 7(10):e47742. PubMed ID: 23082205
    [Abstract] [Full Text] [Related]

  • 3. Bacteriophage can lyse antibiotic-resistant Pseudomonas aeruginosa isolated from canine diseases.
    Furusawa T, Iwano H, Higuchi H, Yokota H, Usui M, Iwasaki T, Tamura Y.
    J Vet Med Sci; 2016 Jul 01; 78(6):1035-8. PubMed ID: 26876365
    [Abstract] [Full Text] [Related]

  • 4. Analyses of Short-Term Antagonistic Evolution of Pseudomonas aeruginosa Strain PAO1 and Phage KPP22 (Myoviridae Family, PB1-Like Virus Genus).
    Uchiyama J, Suzuki M, Nishifuji K, Kato SI, Miyata R, Nasukawa T, Yamaguchi K, Takemura-Uchiyama I, Ujihara T, Shimakura H, Murakami H, Okamoto N, Sakaguchi Y, Shibayama K, Sakaguchi M, Matsuzaki S.
    Appl Environ Microbiol; 2016 Aug 01; 82(15):4482-4491. PubMed ID: 27208109
    [Abstract] [Full Text] [Related]

  • 5. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells.
    Alemayehu D, Casey PG, McAuliffe O, Guinane CM, Martin JG, Shanahan F, Coffey A, Ross RP, Hill C.
    mBio; 2012 Aug 01; 3(2):e00029-12. PubMed ID: 22396480
    [Abstract] [Full Text] [Related]

  • 6. Design of a Broad-Range Bacteriophage Cocktail That Reduces Pseudomonas aeruginosa Biofilms and Treats Acute Infections in Two Animal Models.
    Forti F, Roach DR, Cafora M, Pasini ME, Horner DS, Fiscarelli EV, Rossitto M, Cariani L, Briani F, Debarbieux L, Ghisotti D.
    Antimicrob Agents Chemother; 2018 Jun 01; 62(6):. PubMed ID: 29555626
    [Abstract] [Full Text] [Related]

  • 7. The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model.
    Manohar P, Nachimuthu R, Lopes BS.
    BMC Microbiol; 2018 Aug 31; 18(1):97. PubMed ID: 30170558
    [Abstract] [Full Text] [Related]

  • 8. Isolation of bacteriophages and their application to control Pseudomonas aeruginosa in planktonic and biofilm models.
    Kwiatek M, Parasion S, Rutyna P, Mizak L, Gryko R, Niemcewicz M, Olender A, Łobocka M.
    Res Microbiol; 2017 Apr 31; 168(3):194-207. PubMed ID: 27818282
    [Abstract] [Full Text] [Related]

  • 9. Susceptibility of Pseudomonas aeruginosa veterinary isolates to Pbunavirus PB1-like phages.
    Fujiki J, Furusawa T, Munby M, Kawaguchi C, Matsuda Y, Shiokura Y, Nakamura K, Nakamura T, Sasaki M, Usui M, Iwasaki T, Gondaira S, Higuchi H, Sawa H, Tamura Y, Iwano H.
    Microbiol Immunol; 2020 Nov 31; 64(11):778-782. PubMed ID: 32918505
    [Abstract] [Full Text] [Related]

  • 10. Isolation and Characterization of Three Pseudomonas aeruginosa Viruses with Therapeutic Potential.
    Wang X, Tang J, Dang W, Xie Z, Zhang F, Hao X, Sun S, Liu X, Luo Y, Li M, Gu Y, Wang Y, Chen Q, Shen X, Xu L.
    Microbiol Spectr; 2023 Jun 15; 11(3):e0463622. PubMed ID: 37125933
    [Abstract] [Full Text] [Related]

  • 11. Characterization of five newly isolated bacteriophages active against Pseudomonas aeruginosa clinical strains.
    Kwiatek M, Mizak L, Parasion S, Gryko R, Olender A, Niemcewicz M.
    Folia Microbiol (Praha); 2015 Jan 15; 60(1):7-14. PubMed ID: 24993480
    [Abstract] [Full Text] [Related]

  • 12. Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa.
    Wang J, Hu B, Xu M, Yan Q, Liu S, Zhu X, Sun Z, Reed E, Ding L, Gong J, Li QQ, Hu J.
    Int J Mol Med; 2006 Feb 15; 17(2):309-17. PubMed ID: 16391831
    [Abstract] [Full Text] [Related]

  • 13. Optimizing bacteriophage treatment of resistant Pseudomonas.
    Ulrich L, Steiner LX, Giez C, Lachnit T.
    mSphere; 2024 Jul 30; 9(7):e0070723. PubMed ID: 38934592
    [Abstract] [Full Text] [Related]

  • 14. Piperacillin and ceftazidime produce the strongest synergistic phage-antibiotic effect in Pseudomonas aeruginosa.
    Uchiyama J, Shigehisa R, Nasukawa T, Mizukami K, Takemura-Uchiyama I, Ujihara T, Murakami H, Imanishi I, Nishifuji K, Sakaguchi M, Matsuzaki S.
    Arch Virol; 2018 Jul 30; 163(7):1941-1948. PubMed ID: 29550930
    [Abstract] [Full Text] [Related]

  • 15. Combinations of Bacteriophage Are Efficacious against Multidrug-Resistant Pseudomonas aeruginosa and Enhance Sensitivity to Carbapenem Antibiotics.
    Kovacs CJ, Rapp EM, Rankin WR, McKenzie SM, Brasko BK, Hebert KE, Bachert BA, Kick AR, Burpo FJ, Barnhill JC.
    Viruses; 2024 Jun 21; 16(7):. PubMed ID: 39066163
    [Abstract] [Full Text] [Related]

  • 16. Utility of lytic bacteriophage in the treatment of multidrug-resistant Pseudomonas aeruginosa septicemia in mice.
    Vinodkumar CS, Kalsurmath S, Neelagund YF.
    Indian J Pathol Microbiol; 2008 Jun 21; 51(3):360-6. PubMed ID: 18723958
    [Abstract] [Full Text] [Related]

  • 17. Isolation and characterization of two bacteriophages with strong in vitro antimicrobial activity against Pseudomonas aeruginosa isolated from dogs with ocular infections.
    Santos TM, Ledbetter EC, Caixeta LS, Bicalho ML, Bicalho RC.
    Am J Vet Res; 2011 Aug 21; 72(8):1079-86. PubMed ID: 21801066
    [Abstract] [Full Text] [Related]

  • 18. A novel bacteriophage cocktail reduces and disperses Pseudomonas aeruginosa biofilms under static and flow conditions.
    Alves DR, Perez-Esteban P, Kot W, Bean JE, Arnot T, Hansen LH, Enright MC, Jenkins AT.
    Microb Biotechnol; 2016 Jan 21; 9(1):61-74. PubMed ID: 26347362
    [Abstract] [Full Text] [Related]

  • 19. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients.
    Chang RYK, Das T, Manos J, Kutter E, Morales S, Chan HK.
    AAPS J; 2019 Apr 04; 21(3):49. PubMed ID: 30949776
    [Abstract] [Full Text] [Related]

  • 20. Improving the Inhibitory Effect of Phages against Pseudomonas aeruginosa Isolated from a Burn Patient Using a Combination of Phages and Antibiotics.
    Aghaee BL, Khan Mirzaei M, Alikhani MY, Mojtahedi A, Maurice CF.
    Viruses; 2021 Feb 21; 13(2):. PubMed ID: 33670028
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 70.